Cypress Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,455	Closed	-$387K	–	343
2021 Q4	$387K	Sell	3,455 -9,078	-72%	-$1.09M	0.05%	232
2021 Q3	$1.58M	Sell	12,533 -681	-5%	-$87.7K	0.21%	105
2021 Q2	$1.79M	Buy	13,214 +1,319	+11%	+$173K	0.24%	97
2021 Q1	$1.61M	Buy	11,895 +4,682	+65%	+$701K	0.23%	102
2020 Q4	$1.01M	Buy	7,213 +4,293	+147%	+$550K	0.15%	120
2020 Q3	$325K	Buy	+2,920	New	+$327K	0.05%	212
2019 Q2	–	Sell	-2,339	Closed	-$212K	–	247
2019 Q1	$212K	Sell	2,339 -500	-18%	-$42.5K	0.04%	230
2018 Q4	$204K	Sell	2,839 -7,057	-71%	-$569K	0.05%	227
2018 Q3	$949K	Buy	9,896 +1,504	+18%	+$146K	0.18%	114
2018 Q2	$799K	Buy	+8,392	New	+$771K	0.16%	120